Wednesday, October 28, 2015


Intersection of Big Data and Academic Oncology Research – a Reality Check


The MedicRes Congress is a great opportunity to combine different areas of medical research and will give an insight in the big machinery producing the data on which treatment schedules are changing in different therapy areas. 


Big data in medical research and health care comes with big promises and expectations. My talk shall reflect on the some of the current realities of big date-oncology interaction from the perspective of an academically minded sponsor organization. Additionally, I will formulate our expectations of big data and outline development which may shape clinical oncology in the future.


First, I will briefly describe our role as academic sponsor for oncologic trials and our role as a direct and indirect creator of big data; discuss the motivation and the way our data is used. I will then present some select big data sources (e.g cancer registries, drug safety data bases, electronic patient files) describe how they shape and influence our work today and in the near future. I will describe the way we are producing data and how big data can influence or improve the patient treatment by reducing costs for running expensive trials. The last part of the talk will critically reflect on big data initiatives in oncology in general and I shall take the opportunity to comment on our expectations on what big data should achieve. 

I call upon my colleagues to join the discussion on big data in medical research and to take the opportunity to shape the discourse.



October 19th, 15.30-17.00
The Cooper Union, The Great Hall 7 East 7th Street ,New York,  NY 10003
“Big Data in Oncology  Research” , Aysun Karatas , Chief Executive Officer AIO-Studien-
gGmbH (AIO Working Group of Medical Oncology within the German Cancer Society DKG) 
Berlin Area, Germany

Monday, October 12, 2015

MedicReS 5th World Congress on Good Medical Research

MedicReS 5th World Congress on Good Medical Research


“The Near Future Perspectives in Medical Research:  Biostatistics, Bioethics &Publication Policy in the Age of Big Data”

5th World Congress on Good Medical Research
 Chairs:
Arzu Kanık Ph.D. – MedicReS Scientific Director, Mersin University
David B. Resnik J.D., Ph.D. Bioethicist and IRB Chair - National Institute for Environmental Health 
Sciences NIH

3rd International Good Biostatistical Practice Conference
 Chair:
Arzu Kanık Ph.D. – MedicReS Scientific Director, Professor in Biostatistics,  Mersin University

3rd International Good Bioethical Practice Conference
 Chair:
Collin O'Neill Ph.D., Department of Population Health, NYU Medical Center

3rd International Good Publication Practice Conference
Chair :

Zubin Master Ph.D. Assistant Prof. Alden March  Bioethics Institute, Albany Medical College


October 19th-25th
The Cooper Union, The Great Hall 7 East 7th Street ,New York,  NY 10003

Wednesday, September 30, 2015

The Ethics of Trials that Offer Less than the Best - Dr. Collin O’Neil


The Ethics of Trials that Offer Less than the Best
Dr. Collin O’Neil - Lehman College, City University of New York.


Good Medical Research is research that has the potential to deliver results that can improve the capabilities and decision-making of clinicians, and that obtains its results via methods that respect the rights of human subjects. Settling questions about what counts as good medical research is an interdisciplinary enterprise, requiring contributions from statisticians, scientists, clinicians, and ethicists, and the MedicReS World Congress will be bringing these experts together. 

My subject is the ethics of withholding care from participants in clinical trials.  These trials are usually conducted overseas in settings where the care is unavailable in the local health care system.  The participants are therefore not deprived of anything they would have had access to outside the trial.  But these trials remain controversial because the researchers could prevent the participants from suffering serious harm, and decline to do so.  It is my hope that attendees will come away with a better understanding of the ethics of these trials.  

There is a growing consensus that clinical researchers are justified in doing less than their best for the subjects in their trials when necessary to obtain results that will help future patients more.  I criticize this view on the grounds that it neglects the moral constraint against allowing harm as a means, and describe several trial designs that intend the harmful consequences of withholding care as a means to various research-related ends. 

I hope you will consider attending the 2015 MedicReS World Congress to hear a variety of presentations on the theme of good medical research, and to participate in the conversations they generate. 


October 19th, 15.30-17.00
The Cooper Union, The Great Hall 7 East 7th Street ,New York,  NY 10003
The Ethics of Trials that Offer Less than the Best Dr. Collin O’Neil - Center for Bioethics, NYU

Monday, September 28, 2015

The Importance of Teaching Medical Research Methodology - Dr. İrfan Şencan


The Importance of Teaching  Medical Research Methodology in Medical Specialty Education

İrfan Şencan Professor in Infectious Diseases an Clinical Microbiology Department, Deputy Undersecretary of Turkish Ministry of Health


In my opinion, the Congress will present helpful information on series of topics related to the conduct of biomedical research. The speakers will bring up variety of disciplinary perspectives. The audience will be global.
My subject is significant because methodology is important in order to provide evidence based service and research.
I can shortly summarize my subject with these sentences: I’m going to share knowledge regarding Medical education and education of medical specialty in Turkey with this presentation. I will also share summary knowledge on scientific publishing of health in Turkey. I will explain why we need to MedicRes education. Our expectation from this issue is good health care .
My colleagues should join in that an opportunity for generating information from Big Data.


October 20th, Tuesday 15.30-17.00 
The Cooper Union, The Great Hall 7 East 7th Street ,New York,  NY 10003

"The Importance of Teaching  Medical Research Methodology in Medical Specialty Education" ,  İrfan Şencan, MD, Professor in Infectious Diseases and Clinical Microbiology DePartment , Deputy Undersecretary of Turkish Ministry of Health 


Saturday, September 26, 2015

Invited Speakers

Invited Speakers


David B. Resnik, J.D., Ph.D. Bioethicist and NIEHS IRB Chair
E. Arzu Kanık  PhD. Professor in Biostatistics, MedicReS Scientific Director, Mersin University
Adil E. Shamoo Ph.D., Professor University of Maryland School of Medicine
Rebecca E. Cooney, Ph.D., North American Editor, The Lancet
Zubin Master , Ph.D. Assistant Prof. Alden March  Bioethics Institute, Albany Medical College
Collin O'Neil, Ph.D., Assistant Professor, Department of Philosophy, Lehman College, City 
University of New York 
Denise Esserman, Ph.D.,  Associate Professor of Public Health (Biostatistics), School of Public 
Health: Yale Center for Analytical Sciences (YCAS)
Aysun Karatas MD , Chief Executive Officer AIO-Studien-gGmbH (AIO Working Group of 
Medical Oncology within the German Cancer Society DKG) Berlin Area, German
Monica Gaidhane, MD, MPH, Clinical Research Manager at Weill Cornell Medical
İrfan Şencan MD ,Professor in Infectious Diseases and Clinical Microbiology Department , 
Deputy Undersecretary of Turkish Ministry of Health 
Shing Lee, PhD, Assistant Professor, Biostatistics at the Columbia University Medical Center
Han Liu, Assistant Professor, Department of Operations Research and Financial Engineering
Princeton University


Friday, September 25, 2015

The Future of Frequentist Hypothesis Testing - Dr. Denise A. Esserman





The Future of Frequentist Hypothesis Testing


Dr. Denise A. Esserman 
Yale School of Public Health, Yale University 


The Congress will bring together a diverse group of researchers with differing experience and opinions.  This is a great opportunity to get together and brain storm and ponder about the future of collaborative research.  My subject will discuss where analysis, particularly that of big data, is headed.

My subject will discuss where analysis, particularly that of big data, is headedI will discuss the definition of big data from a biostatistics perspective.  It will review some of the work that has been done and where statistical analyses is headed in the future.  



Please attend the MedicRes World Congress it is a great opportunity to discuss how to advance science using good, ethical practices.


October 20th, Tuesday 9.00-10.30 
The Cooper Union, The Great Hall 7 East 7th Street ,New York,  NY 10003
The Future of Frequentist Hypothesis Testing Dr. Denise A. Esserman  Yale School of Public Health, Yale University 




Thursday, September 24, 2015

Integrity of Authorship in the Age of Collaborative Research - Dr. Adil E. Shamoo


Integrity of Authorship in the Age of Collaborative Research
  Adil E. Shamoo, Ph.D., Professor and Editor- in-Chief, Accountability in Research
University of Maryland School of Medicine






In my opinion, the conference is timely to address the pressing issues in medical research. The intense nature of current progress in medical research necessitates anticipating and dealing with potential ethical and compliance issues. Among the issues of concern are: Integrity of research publications free from falsification, fabrication, and plagiarism.

I find my subject very significant because the integrity of publication free from misconduct is vital to safety of drugs to patients and to the overall process of research.

With the main points, the talk will consist of a short exercise in identifying plagiarism with a fun example. Afterwards, I will discuss examples of plagiarism around the world. I will discuss several safeguards promote integrity of authorship. I will discuss the several models to enhance integrity of authorship among them the contributor model. 

It is certainly worthwhile to attend the conference to participate in the latest issues on enhancing integrity of authorship in medical research.

October 19th Monday
15.30-17.00
The Cooper Union, The Great Hall 7 East 7th Street ,New York,  NY 10003

“Integrity of Authorship in the Age of Collaborative Research”, Adil E. Shamoo Ph.D., Professor University of Maryland School of Medicine